Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Minahasa Membangun Hebat Tbk. (HBAT) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Minahasa Membangun Hebat Tbk.Trade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Minahasa Membangun Hebat Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Minahasa Membangun Hebat Tbk. trades at Rp222 (market cap 220.64B, 547.3K 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is the larger of the two by market cap, and Minahasa Membangun Hebat Tbk. is more actively traded (547.3K versus 41.7K). Which is the better fit depends on your goals.

DGNSHBAT
Market Cap
316.25B220.64B
Volume
41.7K547.3K
Lot
4175.47K
Turnover
9.66M117.51M
Average Price
231.65214.71
Value
9.66M117.51M
Indicative Equilibrium Price
230222
Indicative Equilibrium Volume
2.4K100

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
HBAT
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Minahasa Membangun Hebat Tbk.

PT Minahasa Membangun Hebat Tbk was established based on Notarial Deed No. 44 datedJanuary 31, 2020 of Dian Fitriana, S.H., M.Kn., a public notary in Bekasi.

Read more on HBAT